EFPIA - NEWSLETTER

Trouble reading this email? View it in your browser


		EFPIA Newsletter 5 November 2020

Report: Without orphan drugs law, 2mn patients deprived access to therapies

EFPIA special report for Euractiv

In the absence of the EU orphan drugs regulation, which focuses on rare diseases, approximately two million patients would not get access to therapies, a new industry-funded report has found.

Read more

19 Conversations | The EFPIA podcast series

Podcast: How can we keep SMEs in Europe?
05 November 2020

Welcome to 19 conversations Read more

Blogs

COVID-19 vaccines: a watershed moment for science
04 November 2020 - Magdalena R. de Azero

An interview with Magdalena de Azero, Executive Director, Vaccines Europe Read more

October Liver Cancer Awareness Month, together we are stronger! (Guest blog)
04 November 2020 - Marko Korenjak

ELPA devotes each year the whole month of October to share awareness, information, and essential data regarding HCC... Read more

Rethinking liver cancer: Care for your liver like it cares for you (Guest blog)
04 November 2020 - Bartek Bednarz

Is your liver working too hard? Read more

IMI Impact: collaboration is key to dementia challenge (Guest blog)
03 November 2020 - Frank-Christophe Lintz - Johannes Streffer

More than 20 Innovative Medicines Initiative projects are helping advance dementia research Read more

Did you miss our past virtual events? Watch them again!

Orphan Medicines: how to sustain innovation in an area of high unmet need?
How can we ensure access to new treatments today, medical innovation for tomorrow and sustainable healthcare systems... Read more

Everything You Always Wanted to Know About Drug Shortages (But were afraid to ask)
We all share the same objective: ensuring that patients get the medicines and vaccines they need in a timely way.Read more

Events

International Congress on the Effects of COVID-19 on People with Rare Diseases
09 November 2020 (Virtual event)

New Share4Rare event! On the second week of November, an international conference will take place virtually in order... Read more

IMI Stakeholder Forum 2020
10 November 2020 (Virtual event)

The theme this year is 'Broader horizons: growing Europe’s health partnership'. Read more

Everything You Always Wanted to Know About Drug Shortages (But were afraid to ask)
12 November 2020 (Virtual event)

How can policy promote robust and resilient European supply chains as part of a global framework? Read more

From silo budgeting to financial integration: Where does the EU stand in diabetes care?
20 November 2020 (Online event)

Lessons learned from an EFPIA/The Economist Intelligence Unit study Read more

We published

Strengthening Health Systems Through Smart Spending
15 October 2020 (Publications)

EFPIA has developed a number of policy recommendations for national and European policy-makers to inform a discussion... Read more

What we are reading

Estimated impact of EU Orphan Regulation on incentives for innovation
On 30 October 2020 (Dolon)

This report seeks to understand the relationship between incentives, investment, innovation and patient access to orphan... Read more

2020 EU Health Summit Videos
On 26 October 2020 (EU Health Coalition)

On 26 October, we hosted the second EU Health Summit and we presented our 10 recommendations for a healthier Europe.... Read more

Covid vaccine tracker: when will a coronavirus vaccine be ready?
On 20 October 2020 (The Guardian)

More than 170 teams of researchers are racing to develop a safe and effective vaccine. Here is their progress Read more

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Leopold Plaza Building
Rue du Trône 108
B-1050 Brussels (Belgium)

Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu